Skip to content
Search

Latest Stories

Community pharmacies in NI witnesses highest level of dispensing record in 2022/23

Community pharmacies were responsible for dispensing over 99 per cent of items in 2022/23, revealed General Pharmaceutical Services for Northern Ireland, Annual Statistics 2022/23 published on Thursday (29 June).

While the remaining one per cent dispensed by appliance contractors and dispensing doctors.


According to the statistics, on average, each community pharmacy dispensed over 84,000 items in 2022/23, witnessing a growth of over 3 per cent on the previous year to 44.6 million in 2022/23, which is the highest level of dispensing recorded.

This equated to BSO processing 2.1 million prescription forms per month, on average, throughout the year, representing a 4 per cent increase on the just over 2.0m processed each month last year.

The total ingredient cost over the year was £486.9 million. This was an increase of approaching 7 per cent on the previous year, which was around double the percentage increase in the number of items dispensed. The annual ingredient cost total has fluctuated since the beginning of the series but was over 18 per cent higher in 2022/23 than in 2013/14.

Approximately one-quarter (25%) of all items dispensed in 2022/23 were categorised as mainly treating conditions of the Central Nervous System. These items accounted for over one fifth (21%) of total ingredient cost.

Around 45 per cent of prescription items for which the age of the patient could be determined were dispensed to patients aged 65 or over, with over one-third (34%) dispensed to patients in the 45 to 64 age group.

The number of items dispensed in the most deprived areas in Northern Ireland was 46 per cent higher than in the least deprived. Conversely, the average ingredient cost per item was over 20 per cent higher in the least deprived areas.

One in four females (25%) in Northern Ireland received anti-depressant medication during 2022/23. The equivalent figure for males was 15 per cent. The proportion of the population receiving anti-depressant medication was over one and a half times higher in most deprived areas compared with the most affluent.

Northern Ireland had the highest ingredient cost per person in the UK in the 2022 calendar year, at just over £245. This was almost 40 per cent  higher than England, where the ingredient cost per person was just over £176 in 2022.

The report also revealed that by the end of 2022/23, Northern Ireland had 525 community pharmacies, one fewer than last year.

It also highlighted that people in Northern Ireland live, on average, less than one mile from a community pharmacy. However, there is a distinct variation in urban and rural settings, with Belfast Local Government District residents living, on average, 0.3 miles from their nearest pharmacy, compared with 1.6 miles for those living in Fermanagh and Omagh.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less